The first-year safety and efficacy data of an asynchronous system during the COVID-19 pandemic revealed a possible way to reduce patient waiting times.
Sometimes only apparent after years of therapy, these include eyelid malposition and lacrimal drainage obstruction. Chronic inflammation is the likely culprit.